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Regulated expression of complement factor B in the human kidney. We
have previously demonstrated regulated expression of C3 in the proximal
renal tubular epithelial cells of humans. To test the hypothesis that local
alternative pathway complement activation could contribute to the tubu-
lointerstitial component of chronic renal disease, we examined factor B
gene expression in human kidneys. 35S riboprobes were generated from a
human factor B cDNA. By in Situ hybridization, proximal tubular factor B
message was seen in 17 kidneys with various nephropathies. The expres-
sion was most intense in organs with evidence of interstitial inflammation,
and its localization paralleled the inflammation. As was the case with C3
and C4, there was never any evidence of glomerular factor B message, nor
was any seen in infiltrating inflammatory cells. In eight normal kidney
tissues, factor B expression was either absent or restricted to rare foci of
interstitial infiltration. The proximal renal tubular epithelium of humans
appears to express the genes for both components of the alternative
pathway convertase, C3 and factor B. These locally produced components
may be important mediators of the interstitial inflammation that is
common to all progressive nephritides.
Recent work in our laboratory has shown that the genes for two
complement components, C4 and C3, are expressed in the human
kidney. The nature of their expression differs, however, and may
relate to a potential role in immune renal disease.
C4 is expressed constitutively by the proximal tubular epithe-
hum [1]. The distribution and intensity of renal C4 expression
does not appear to differ between normal kidneys and organs with
a variety of inflammatory disorders. Thus, although it may play a
role in local immunity, it is unlikely that renal C4 synthesis is
important in human disease.
The situation with C3 differs considerably from that of C4.
Although C3 message is also present in the proximal renal tubular
epithelium, its expression is differentially regulated [2]. C3 mRNA
is found only in tubules derived from abnormal glomeruli. Tu-
bules positive for C3 by in situ hybridization are often surrounded
by an inflammatory infiltrate and peritubular edema. C3 protein is
present in tubular cell cytoplasm and C3d is deposited on the
tubular basement membrane. Neither the infiltrating cells them-
selves nor cells in the glomerulus synthesize C3.
We have hypothesized that this local tubular C3 synthesis may
play an important role in mediating the interstitial injury that
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accompanies severe, progressive glomerulonephritis. C3 expres-
sion may be induced by glomerular cytokines, which access the
tubular epithelium via the urine or the vasa rectae. The C3 protein
may then be secreted into the ammonia-rich peritubular intersti-
tium, where it may be amidated [31. Amidated C3 may then
become part of a C3 convertase, and in turn may generate
additional C3b. This activation of the complement cascade may
injure tubules directly and may attract other inflammatory medi-
ators to the peritubular environment. This, in turn, may be a
major factor in inducing the tubulointerstitial injury that invari-
ably heralds the progression of glomerulonephritis to end-stage
renal disease.
This hypothesis requires that the other components of the
alternative pathway convertase also be locally available. Factor D,
a low molecular weight protein, is probably ubiquitous in tissue
fluid. There are, however, no data speaking to the availability of
factor B in the renal interstitium. We have therefore examined
human kidney tissue for evidence of local synthesis of this
component.
Methods
Tissues
Fresh human kidney tissue was obtained at the time of nephrec-
tomy or open or percutaneous renal biopsy, snap frozen in liquid
nitrogen, and stored at —70°C. Non-tumor-containing areas of
kidneys removed because of Wilms' tumor were considered
"normal" tissues on the basis of negative findings by light,
immunofluorescence, and electron microscopy.
Nucleic acid probes
The plasmid pGEM.Bf was obtained from the American Type
Culture Collection (Rockville, MD, USA). The 222-bp fragments
containing exons 10 and 11 were amplified by the polymerase
chain reaction in a thermal cycler (Perkin-Elmer Cetus Instru-
ments, Norwalk, CT, USA). The primers, which incorporate
recognition sequences for T3 (coding strand) and T7 (anti-coding
strand), were:
Coding. 5 '-TFGIGAT/CCAiTI7AJACCICTCIACTIAAAJGGGI
AAT/GTG,TflT/GGG/GTCIGGGICCT-3'
Anticoding. 5'-TTG/GATICCT/AATIACGIACT/CACITAT/
AGG/GAC/CAT/GCC/ACAJGAG/ACT/CAG-3'
For use as a positive control, a human B actin cDNA [41 was
used to generate fragments using the following primers:
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Fig. 2. Immunohistochemical localization of Factor B protein in human kidney samples. A. Renal tissue from a patient with MPGN type TI and end-stage renal
disease. There is strong immunofluorescence for factor B protein in the tubular epithelial cells. B. Normal renal tissue from a kidney resected with Wilms'
tumor which was stained for factor B protein. None of the tubules show evidence of factor B expression. (FITC, Propidium iodide counterstain, X300).
Coding. 5' -TFG/GAT/CCA/TTA/ACC/CTC/ACT/AAAJGGG/
AGCICGUICTT/CGCIGGG/CGAICGA-3'
Anticoding. 5 '-TFG/GAT/CCT!AAT/ACG/ACT/CAC/TAT/
AGGIGTCIAGGITCCICGG!CCA/GCCIAGG-3'
After subcloning with pBluescript II (Stratagene, La Jolla, CA,
USA), sense and antisense probes were transcribed in the pres-
ence of 35S, using T3 and T7 polymerase, respectively. The probes
were passed over Quick Spin columns (Boehringer-Mannheim
Corp., Indianapolis, IN, USA) to remove unincorporated nude-
otide before use.
The preparation of C3 probes has been reported by us previ-
ously [2].
In situ hybridization method
Cryostat sections (12 jxm) of frozen tissue were air dried onto
microscope slides coated with 3-aminopropyltriethoxysilane (Sig-
ma Immunochemicals, St. Louis, MO, USA). After fixation for
one hour in 4% paraformaldehyde in phosphate-buffered saline,
slides were washed with 70% ethanol and 2 x SSC (20 X SSC is
3 M NaC1, 0.3 M Na3C6H5O7 2H20, pH 7). Sections were
digested for five minutes at room temperature in 20 rg/ml
proteinase K in 0.2 M Tris pH 8.3. After a wash in 2 x SSC,
sections were acetylated in 0.25% acetic anhydride in 0.1 M
triethanolamine, pH 8 (vol/vol) for 10 minutes, dehydrated in
graded ethanols, and air dried. Sections were prehybridized at
42°C for 15 minutes by overlaying 50 pJ of a solution of 50%
formamide (E.M. Science, Cherry Hill, NJ, USA), 2 X SSC, IX
Denhardt's solution, 10% dextran sulfate, 750 xg/ml yeast transfer
RNA, 750 xg/ml herring sperm DNA, 5 mrvi DTT, 100 xg/ml BSA,
and 74 jxM 4-thiouridine 5' monophosphate (thio-UMP) (Sigma
Immunochemicals). Fresh prehybridization solution (25 p1),
which lacked thio-UMP but contained 2 x i0 cpm/ml of S-
labeled RNA probe, was added to each section and allowed to
hybridize overnight at 42°C under a coverslip sealed with rubber
cement. After the coverslips were removed and the sections
rinsed, unhybridized probe was digested with a mixture of 50
xg/ml RNase A and 100 1irl/ml RNase Ti (Boehringer-Mann-
heim) for 30 minutes at 37°C. Sections were washed in 50%
formamide in 1 x SSC at 50°C and, most stringently, with 0.1 X
SSC at 55°C. All washes contained 1 mrvt DTT The slides were
then dehydrated, dipped in Kodak NTB2 emulsion, exposed for
10 to 20 days at 4°C, developed, and counterstained with hema-
toxylin and eosin.
Tissue analysis
Sequential sections from each tissue specimen were hybridized
with the 35S-labeled antisense riboprobe to identify B message
and with a sense riboprobe (for B or C3) as a negative control.
Most were also examined with the B actin antiscnse riboprobe as
a positive control. Sections were examined by three investigators,
and considered adequate if cortex was present and if there was no
Fig. 1. Localization of factor B mRNA by in situ hybridization in renal tubular epithelium. A. A section through the cortex of normal kidney tissue from
a kidney resected for a Wilms' tumor. The section was hybridized with 35S labeled antisense probe for factor B mRNA. No signal is observed in the
tissue. B. A serial section of the tissue illustrated in panel A, but was hybridized with the control sense probe for factor B to show the background level
of nonspecific signal. C. A section of kidney from a kidney resected for Wilms' tumor. There is a focus with strong signal (white grains) in the tubular
epithelium of the tubules surrounded by an inflammatory infiltrate. No significant signal is present in the glomeruli or the inflammatory cells, and the
remaining tubules show only low level signal. D. A higher magnification of the section illustrated in panel C and with bright field illumination. The
tubules with the strong signal as shown in panel D are surrounded by a prominent interstitial inflammatory infiltrate (arrowheads). E. A Section fr9m
a dysplastic end-stage kidney. There is a strong signal, indicating the presence of factor B mRNA in the epithelial cells lining a tubule surrounded by
intense chronic inflammation. No signal is present in the inflammatory cells. F. A section from a kidney with severe MPGN type II. There are groups
of tubules with strong signal in the epithelial lining cells. The glomeruli (°) are negative, although some signal is seen in tubularized crescents
(arrowhead) surrounding a glomerulus. G. A section of kidney from a patient with lupus nephritis. Many of the tubules show strong signal however the
glomeruli are negative (*). H. A section of a kidney biopsy from a patient with IgA nephropathy. Many of the tubular epithelial cells show high level
expression of factor B (A—C, E—H, dark field illumination at X 120; D, bright field illumination at X 300).
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Table 1. B expression in human kidneys
Number Diagnosis B expression pattern
Negative or
insignificant
1 Normal Negative
2 Normal Negative
3 Normal Negative
4 Normal Negative
5 Normal Negative
6 Normal Negative
7 Normal Single focus of positive tubules in area of interstitial inflammation
8 Normal Single focus of positive tubules in area of interstitial inflammation
9 Membranous nephropathy Negative
10 Congenital nephrotic syndrome Single focus of positive interstitial inflammation
Focal
11 Diabetic nephropathy Foci of positive tubules coinciding with areas of patchy tubular atrophy
12 SLE glomerulonephritis Foci of positive tubules coinciding with areas of pen-tubular inflammation
13 SLE glomerulonephritis Foci of positive tubules coinciding with areas of pen-tubular inflammation
14 SLE glomerulonephritis Foci of positive tubules coinciding with areas of patchy tubular inflammation
15 SLE glomerulonephritis Foci of positive tubules coinciding with areas of patchy tubular inflammation
16 HSP glomerulonephritis Foci of positive tubules coinciding with areas of patchy tubular inflammation
17 HSP glomerulonephritis Foci of positive tubules coinciding with areas of patchy tubular inflammation
18 IgA nephropathy Foci of positive tubules coinciding with areas of patchy tubular inflammation
19 Pyelonephnitis (ESRD) Foci of positive tubules coinciding with areas of patchy tubular atrophy
Diffuse
20 Transplant rejection (acute) Generalized tubular signal, usually surrounded by infiltrating cells
21 Transplant rejection (acute) Generalized tubular signal, usually surrounded by infiltrating cells
22 Transplant rejection (hyperacute) Generalized tubular signal
23 ESRD Generalized tubular signal, most intense in areas of peritubular inflammation
24 Membranoproliferative
glomerulonephritis II (ESRD)
Generalized tubular signal, most intense in areas of peritubular inflammation;
sparing of glomeruli and vessels
25 Pyelonephritis (ESRD) Generalized tubular signal, most intense in areas of tubular atrophy and
penitubular inflammation
significant tissue degradation. The sections were examined by
transmitted light to assess histology and by dark field illumination
to assess B mRNA expression. The pattern of in situ hybridization
positivity was designated "focal" or "diffuse" as previously defined
[2]. Careful attention was given to areas of positive signal in order
to distinguish the cells of origin of the message as well as the
presence of adjacent infiltrating cells. We have found that pat-
terns of tissue expression are much more easily defined by
examination under dark field illumination than with more con-
ventional transmitted light examination. The prominence of signal
with dark field examination is particularly useful in defining
patterns at low magnifications, where the signal is often difficult to
resolve by conventional methods.
Immunohistochemistry
Selected cases which included patients with various types of
glomerulonephnitis and normal kidney tissue from Wilms' tumor
resections were subjected to immunohistochemistry, in order to
establish the presence of factor B protein. Cryostat sections were
incubated with an FITC-conjugated goat antibody to human
Factor B (Altantic Antibodies, Stillwater MN, USA) diluted 1:4 in
PBS for 45 minutes, washed in PBS and examined with a Zeiss
epiflouresence microscope.
Results
In situ hybridization
Adequate tissue for in situ hybridization analysis was available
from 25 human kidney samples, 8 of which were normal and 17 of
which were from patients with various nephropathies.
Six of the normal kidneys showed no signal with the factor B
probe (Table 1 and Fig. 1A). The other two were generally
negative, except for occasional rare foci of signal in proximal
tubules. In these cases, the tubules were in areas of tissue in which
a focal interstitial inflammatory reaction was present.
The other 15 abnormal kidneys were all positive for B message
by in situ hybridization. The signal localized to the tubular
epithelial cells and intensity and localization of this gene expres-
sion roughly corresponded to the location and intensity of the
interstitial inflammatory component (Fig. 1 E-H). There was
never evidence of B expression in glomeruli or in any infiltrating
inflammatory cells.
In all cases, sense-strand controls were negative (Fig. 1B). The
B-actin probes showed widespread distribution in all tissues
examined.
Most of the abnormal kidneys had been previously examined by
us for C3 gene expression [2], and others were examined for this
study. In all cases, abnormal tissues expressing B also expressed
C3, in a similar distribution. For example, Figure iF corresponds
to the tissue examined for C3 in Figure 2B, reference 2. The
extensive tubular signal, the signal in tubularized crescents, and
the absent glomerular signal for both components was identical in
this tissue.
Immunohistochemistiy
The normal kidneys showed no evidence of factor B staining
except in a few small clusters of tubules similar to the occasional
tubules identified in the in situ hybridization analyses (Fig. 2B). In
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contrast, in the kidney biopsy samples from patients with glomer-
ulonephritis, multiple foci were identified with a strong immuno-
fluorescent label in the tubular epithelial cells, indicating the
presence of factor B protein. There was no reaction in the control
sections when the primary antibody was omitted.
Discussion
When the data in this study are viewed in the context of other
recently published work from our laboratory [21, it appears that
the human kidney is capable of synthesizing the two major
components of the alternative pathway C3 convertase, C3 and
factor B. One study of human kidney complement synthesis
suggested that either resident glomerular or infiltrating cells were
the source of the protein [5]. This led to the hypothesis that locally
synthesized complement components were important mediators
of glomerular inflammation. A more recent study of isolated
human mesangial cells [6] reported baseline C3 gene expression
and protein synthesis, which could be up-regulated by cytokines.
It appears clear, however, both from our in situ work [1, 2] and
from other work with cell culture [71, that human renal comple-
ment component synthesis is a tubular, not a glomerular function.
This is analogous to the situation with B1O.PL mice [8]. Thus, the
glomerular complement deposits that are found in many immune
glomerulonephritides likely originate in the circulation. Although
these observations do not support a role for locally synthesized
complement components in glomerular inflammation, they do
support an alternative hypothesis.
It is increasingly recognized that the progression of glomerulo-
nephritis to end-stage renal disease is invariably accompanied by
injury to the tubulointerstitial area [9]. This injury may range from
peritubular inflammation and edema to fibrosis and tubular
atrophy. The mechanisms by which glomerular injury progresses
to interstitial damage are not well understood. We have hypoth-
esized that tubular complement synthesis could be one such
mechanism.
We have previously demonstrated that glomerular inflamma-
tion may up-regulate tubular C3 gene expression, possibly via
cytokines such as IL-i and IL-6. From immunohistochemistry, we
also know that this message is translated and that functional
protein gains access to the peritubular region [2].
With the demonstration in these studies that factor B is also
expressed in proximal tubular cells, the potential exists for an
alternative pathway convertase being generated from locally
synthesized components. Factor D, also necessary for the gener-
ation of a convertase, is a low molecular weight protein that is
probably ubiquitous in tissue fluid. Since it appears that the
distribution of C3 and B gene expression is parallel, these genes
may be responding to the same regulatory stimuli.
The generation of a convertase in the peritubular microen-
vironment could result in a number of deleterious effects.
Cleavage of C3 releases the C3a fragment, a potent anaphyla-
toxin. If a C5 convertase were in turn to be generated, another
potent peptide, C5a, could also be present locally. C3b and C5b
generated locally could bind to the surfaces of adjacent cells,
leading to further direct injury or signaling the production of
other mediators.
In addition to the established role of deposited complement in
mediating glomerular inflammation, regulated local synthesis of
complement protein may provide a link between glomerular and
interstitial injury.
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